| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Neuroscience (B.X., S.P.K.), Physiology (M.G.D., P.S.K.), and Surgery (A.K., L.L.M.) and ICBR (W.G.F.), University of Florida College of Medicine, Gainesville, Florida 32610; and Amgen, Inc. (D.M.), Boulder, Colorado 80301
Address all correspondence and requests for reprints to: Satya P. Kalra, Ph.D., Department of Neuroscience, University of Florida College of Medicine, P.O. Box 100244, Gainesville, Florida 32610-0244. E-mail: skalra{at}neocortex.health.ufl.edu
Although ciliary neurotropic factor (CNTF) is a tropic factor in nervous system development and maintenance, peripheral administration of this cytokine also causes severe anorexia and weight loss. The neural mechanism(s) mediating the loss of appetite is not known. As hypothalamic neuropeptide Y (NPY) is a potent orexigenic signal, we tested the hypothesis that CNTF may adversely affect NPYergic signaling in the hypothalamus. Intraperitoneal administration of CNTF (250 µg/kg) daily for 4 days significantly suppressed 24-h food intake in a time-dependent manner and decreased body weight. The loss in body weight was similar to that which occurred in pair-fed (PF) rats. As expected, hypothalamic NPY gene expression, determined by measurement of steady state prepro-NPY messenger RNA by ribonuclease protection assay, significantly increased in PF rats in response to energy imbalance. However, despite a similar loss in body weight, there was no increase in NPY gene expression in CNTF-treated rats. Daily administration of CNTF intracerebroventricularly (0.5 or 5.0 µg/rat) also produced anorexia and body weight loss. In this experiment, negative energy balance produced by both PF and food deprivation augmented hypothalamic NPY gene expression. However, despite reduced intake and loss of body weight, no similar increment in hypothalamic NPY gene expression was observed in CNTF-treated rats. In fact, in rats treated with higher doses of CNTF (5.0 µg/rat), NPY gene expression was reduced below the levels seen in control, freely fed rats. Furthermore, CNTF treatment also markedly decreased NPY-induced feeding. These results suggested that anorexia in CNTF-treated rats may be due to a deficit in NPY supply and possibly in the release and suppression of NPY-induced feeding. The possibility that CNTF-induced anorexia may be caused by increased leptin was next examined. Daily intracerebroventricular injections of leptin (7 µg/rat) decreased food intake, body weight, and hypothalamic NPY gene expression in a manner similar to that seen after CNTF treatment. Leptin administration also suppressed NPY-induced feeding. However, peripheral and central CNTF injections markedly decreased leptin messenger RNA in lipocytes, indicating a deficiency of leptin in these rats; thus, leptin was unlikely to be involved in appetite suppression. Thus, these results show that a two-pronged central action of CNTF, causing diminution in both NPY availability and the NPY-induced feeding response, may underlie the severe anorexia. Further, unlike other members of the cytokine family, suppression of NPYergic signaling in the hypothalamus by CNTF does not involve up-regulation of leptin, but may involve a direct action on hypothalamic NPY neurons or on neural circuits that regulate NPY signaling in the hypothalamus.
This article has been cited by other articles:
![]() |
J. M. Mercader, J. J. Lozano, L. Sumoy, M. Dierssen, J. Visa, M. Gratacos, and X. Estivill Hypothalamus transcriptome profile suggests an anorexia-cachexia syndrome in the anx/anx mouse model Physiol Genomics, November 12, 2008; 35(3): 341 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Mercader, E. Saus, Z. Aguera, M. Bayes, C. Boni, A. Carreras, E. Cellini, R. de Cid, M. Dierssen, G. Escaramis, et al. Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders Hum. Mol. Genet., May 1, 2008; 17(9): 1234 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Kamiji and A. Inui Neuropeptide Y Receptor Selective Ligands in the Treatment of Obesity Endocr. Rev., October 1, 2007; 28(6): 664 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Escartin, K. Pierre, A. Colin, E. Brouillet, T. Delzescaux, M. Guillermier, M. Dhenain, N. Deglon, P. Hantraye, L. Pellerin, et al. Activation of Astrocytes by CNTF Induces Metabolic Plasticity and Increases Resistance to Metabolic Insults J. Neurosci., July 4, 2007; 27(27): 7094 - 7104. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Foster-Schubert and D. E. Cummings Emerging Therapeutic Strategies for Obesity Endocr. Rev., December 1, 2006; 27(7): 779 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Gosman, H. I. Katcher, and R. S. Legro Obesity and the role of gut and adipose hormones in female reproduction Hum. Reprod. Update, September 1, 2006; 12(5): 585 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Steinberg, M. J. Watt, B. C. Fam, J. Proietto, S. Andrikopoulos, A. M. Allen, M. A. Febbraio, and B. E. Kemp Ciliary Neurotrophic Factor Suppresses Hypothalamic AMP-Kinase Signaling in Leptin-Resistant Obese Mice Endocrinology, August 1, 2006; 147(8): 3906 - 3914. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee, J. W. Bullen Jr., V. L. Stoyneva, and C. S. Mantzoros Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E625 - E632. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bluher, S. Moschos, J. Bullen Jr., E. Kokkotou, E. Maratos-Flier, S. J. Wiegand, M. W. Sleeman, and C. S. Mantzoros Ciliary Neurotrophic FactorAx15 Alters Energy Homeostasis, Decreases Body Weight, and Improves Metabolic Control in Diet-Induced Obese and UCP1-DTA Mice Diabetes, November 1, 2004; 53(11): 2787 - 2796. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Korner and L. J. Aronne Pharmacological Approaches to Weight Reduction: Therapeutic Targets J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2616 - 2621. [Full Text] [PDF] |
||||
![]() |
M. P. Davis, R. Dreicer, D. Walsh, R. Lagman, and S. B. LeGrand Appetite and Cancer-Associated Anorexia: A Review J. Clin. Oncol., April 15, 2004; 22(8): 1510 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Sleeman, K. Garcia, R. Liu, J. D. Murray, L. Malinova, M. Moncrieffe, G. D. Yancopoulos, and S. J. Wiegand Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice PNAS, November 25, 2003; 100(24): 14297 - 14302. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Ettinger, T. W. Littlejohn, S. L. Schwartz, S. R. Weiss, H. H. McIlwain, S. B. Heymsfield, G. A. Bray, W. G. Roberts, E. R. Heyman, N. Stambler, et al. Recombinant Variant of Ciliary Neurotrophic Factor for Weight Loss in Obese Adults: A Randomized, Dose-Ranging Study JAMA, April 9, 2003; 289(14): 1826 - 1832. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zvonic, P. Cornelius, W. C. Stewart, R. L. Mynatt, and J. M. Stephens The Regulation and Activation of Ciliary Neurotrophic Factor Signaling Proteins in Adipocytes J. Biol. Chem., January 17, 2003; 278(4): 2228 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Ahima, H. R. Patel, N. Takahashi, Y. Qi, S. M. Hileman, and M. A. Zasloff Appetite Suppression and Weight Reduction by a Centrally Active Aminosterol Diabetes, July 1, 2002; 51(7): 2099 - 2104. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Morley Decreased Food Intake With Aging J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2001; 56(90002): 81 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Kalra Circumventing leptin resistance for weight control PNAS, April 10, 2001; 98(8): 4279 - 4281. [Full Text] [PDF] |
||||
![]() |
P. D. Lambert, K. D. Anderson, M. W. Sleeman, V. Wong, J. Tan, A. Hijarunguru, T. L. Corcoran, J. D. Murray, K. E. Thabet, G. D. Yancopoulos, et al. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity PNAS, March 16, 2001; (2001) 61034298. [Abstract] [Full Text] |
||||
![]() |
J.-Y. Li, S. Finniss, Y.-K. Yang, Q. Zeng, S.-Y. Qu, G. Barsh, C. Dickinson, and I. Gantz Agouti-Related Protein-Like Immunoreactivity: Characterization of Release from Hypothalamic Tissue and Presence in Serum Endocrinology, June 1, 2000; 141(6): 1942 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. DE JONG-BRINK, C. N. REID, C. P. TENSEN, and A. TER MAAT Parasites flicking the NPY gene on the host's switchboard: why NPY? FASEB J, November 1, 1999; 13(14): 1972 - 1984. [Abstract] [Full Text] |
||||
![]() |
M. Yokosuka, P. S. Kalra, and S. P. Kalra Inhibition of Neuropeptide Y (NPY)-Induced Feeding and c-Fos Response in Magnocellular Paraventricular Nucleus by a NPY Receptor Antagonist: A Site of NPY Action Endocrinology, October 1, 1999; 140(10): 4494 - 4500. [Abstract] [Full Text] |
||||
![]() |
A. Inui Cancer Anorexia-Cachexia Syndrome: Are Neuropeptides the Key? Cancer Res., September 1, 1999; 59(18): 4493 - 4501. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-S. Yeh and M. W Schuster Geriatric cachexia: the role of cytokines Am. J. Clinical Nutrition, August 1, 1999; 70(2): 183 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xu, P. S. Kalra, W. G. Farmerie, and S. P. Kalra Daily Changes in Hypothalamic Gene Expression of Neuropeptide Y, Galanin, Proopiomelanocortin, and Adipocyte Leptin Gene Expression and Secretion: Effects of Food Restriction Endocrinology, June 1, 1999; 140(6): 2868 - 2875. [Abstract] [Full Text] |
||||
![]() |
C. Bjørbæk, J. K. Elmquist, K. El-Haschimi, J. Kelly, R. S. Ahima, S. Hileman, and J. S. Flier Activation of SOCS-3 Messenger Ribonucleic Acid in the Hypothalamus by Ciliary Neurotrophic Factor Endocrinology, May 1, 1999; 140(5): 2035 - 2043. [Abstract] [Full Text] |
||||
![]() |
S. P. Kalra, M. G. Dube, S. Pu, B. Xu, T. L. Horvath, and P. S. Kalra Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight Endocr. Rev., February 1, 1999; 20(1): 68 - 100. [Abstract] [Full Text] |
||||
![]() |
P. D. Lambert, K. D. Anderson, M. W. Sleeman, V. Wong, J. Tan, A. Hijarunguru, T. L. Corcoran, J. D. Murray, K. E. Thabet, G. D. Yancopoulos, et al. From the Cover: Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity PNAS, April 10, 2001; 98(8): 4652 - 4657. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |